Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality

被引:83
作者
Canfell, Karen [1 ]
Sitas, Freddy
Beral, Valerie
机构
[1] NSW Canc Council, Canc Epidemiol Res Unit, Sydney, NSW, Australia
[2] Univ Oxford, Canc Epidemiol Unit, Oxford, England
关键词
D O I
10.5694/j.1326-5377.2006.tb00661.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To compare cervical screening policy, screening uptake, and changes in cervical cancer incidence and mortality between Australia and the United Kingdom. Design: Analysis of screening registry data and national cancer statistics. Setting: In Australia, organised cervical screening was initiated in 1991 for sexually active women aged 18-69 years, with a recommended 2-yearly interval. In the UK, organised screening began in 1988 for women aged 20-64 years, with a recommended 3-yearly interval in most regions. Results: Estimated lifetime screening participation rates in 2001 were similar in the two countries, at 88% in Australia and 90% in the UK. For women who were screened and had a negative result, the median time to the next screen was 27 months in Australia and 38 months in the UK. At 39 months, equivalent proportions (74%) had been re-screened in the two countries, and by 60 months the re-screened proportions were 81% in Australia and 94% in the UK. From 1991-1993 to 1998-2000, the incidence of cervical cancer in women aged 20-69 years fell by 33% in Australia and 33% in the UK, and mortality from cervical cancer fell by 36% in both countries. Conclusions: After the introduction of organised screening, similar reductions in cervical cancer incidence and mortality were achieved in Australia and the UK. Therefore, the 2-yearly screening policy in Australia and the predominantly 3-yearly screening policy in the UK appear to have been of broadly similar effectiveness.
引用
收藏
页码:482 / 486
页数:5
相关论文
共 38 条
[21]  
International Collaboration of Epidemiological Studies of Cervical Cancer, 2006, Int J Cancer, V118, P1481, DOI 10.1002/ijc.21493
[22]  
Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO
[23]  
2-Q
[24]  
*MED AUSTR, 2005, PIP NEWS UPD
[25]   Outcome after a cervical cytology report of low-grade squamous abnormality in Australia [J].
Mitchell, H .
CANCER CYTOPATHOLOGY, 2005, 105 (04) :185-193
[26]   Early cervical cancer rescreening [J].
Morrell, S ;
Mamoon, H ;
O'Callaghan, J ;
Taylor, R ;
Ross, J ;
Wain, G .
JOURNAL OF MEDICAL SCREENING, 2002, 9 (01) :26-32
[27]   Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study [J].
Moss, S ;
Gray, A ;
Legood, R ;
Vessey, M ;
Patnick, J ;
Kitchener, H .
BRITISH MEDICAL JOURNAL, 2006, 332 (7533) :83-85
[28]  
*NAT HLTH MRC, 2005, SCREEN PREV CERV CAN
[29]  
*NAT HLTH SERV CAN, 2004, NHSCSP PUBL, V20
[30]  
*NSW CERV SCREEN P, 2001, NSW PAP TEST REG ANN